These differences between VDAC1 expression in cancers (overexpression) and in PAs (underexpression) may occur due to the distinct effects of this gene on apoptosis in these tumors; however, further studies on VDAC1 expression in pituitary carcinomas may contribute to a greater understanding of these findings. This evidence concerns the gene VDAC1 and gonorrhea.